
Non-profit drug maker will provide insulin for no more than $30 a vial
CNN
Civica Rx, a nonprofit generic drug maker backed by hospitals, insurers and philanthropies, plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval. Insulin has been a poster child for the soaring cost of prescription drugs.
Insulin, which more than 8 million Americans with diabetes depend on, has been a poster child for the soaring cost of prescription drugs.
Though insulin was discovered more than a century ago and costs little to make, the list price of the brand name products that Civica Rx is targeting is roughly $300 per vial, according to the Gary and Mary West Foundation, which co-founded Civica Rx. The cost has nearly tripled since 2010.

Oklahoma’s governor picks energy executive Alan Armstrong to fill US Senate seat through end of year
Oklahoma’s governor on Tuesday appointed energy executive Alan Armstrong to serve in the US Senate through the end of the year and finish the term of Republican Markwayne Mullin, the new homeland security secretary.












